Despite HPV Vaccine, Cervical Cancer Rates Keep Rising

Written by Dr Joseph Mercola on March 22, 2023. Posted in Current News

It was hailed as a breakthrough that would slash levels of this deadly disease, but 17 years later there is a ‘troubling spike,’ despite 80 percent being ‘protected’

Regardless, here’s the medical gaslighting technique they’re using to fool the public.

More than 200 strains of human papillomavirus (HPV) have been identified, and about 40 of them can cause cancer, including cervical, penile, oral, vaginal, vulvar and anal cancer.

Of these, cervical cancer is the most common type of HPV-related cancer in the U.S. Some strains are also responsible for genital warts.[1]

Ninety percent of HPV infections resolve on their own without treatment, as a well-functioning immune system will keep the virus in check. In rare cases, however, infection with a high-risk HPV that remains untreated and unchecked may turn into cancer.

In the U.S., three percent of all cancers in women and two percent of cancers in men are related to untreated chronic HPV infection.[2] Because HPV infection rarely produces symptoms until it has turned cancerous, women are advised to get a Pap smear at least once every three to five years, which will identify the presence of HPV.

HPV Vax Has Failed Miserably to Reduce Cervical Cancer Rates

In 2006, the first HPV vaccine, Gardasil, was licensed; first in Europe in February,[3] followed by the U.S. that June.[4] The vaccine was hailed as a breakthrough that would slash cervical cancer rates, but in the real world, it has largely failed to deliver.

When Gardasil was first introduced, HPV researcher Dr. Diane Harper predicted it would take 60 years of vaccinating at least 70 percent of all 11-year-old girls to reduce cervical cancer rates in the U.S., due to the country’s highly successful Pap testing.

Now, almost 17 years after the vaccine was introduced, there is a “troubling spike” in cervical cancer rates,[5] despite vaccination rates as high as 80 percent[6] (although rates vary widely between gender and ethnic groups.

In 2019, 73 percent of female teenagers had received one dose and 57 percent had received both doses in the series).[7] As reported in the December 2022 issue of the International Journal of Gynecological Cancer:[8]

“Over the last 18 years [2001 through 2018], 29,715 women were diagnosed with distant stage cervical carcinoma … When examining the trends over time, there has been an annual increase in distant stage cervical cancer at a rate of 1.3 percent per year.

The largest increase is seen in cervical adenocarcinoma with an average annual percent change of 2.9 percent.”

Cancers Associated With Vaccine Strains Have Declined

Despite lingering questions about its effectiveness, the medical establishment still hails the HPV vaccine as a success, as cervical cancers associated with the vaccine strains have in fact decreased.

Since 2006, cancers associated with the four HPV strains included in the original quadrivalent vaccine have declined by 88 percent among 14- to 19-year-olds and 81 percent among women aged 20 to 24.[9] Aside from the fact that only 14 cases of cervical cancer a year were occurring in females aged 15 to 19 before the vaccine[10] (meaning an 88 percent drop isn’t all that impressive), the drop may not be all due to the vaccine, as rates have also declined among unvaccinated women.

What’s more, when looking at HPV-related cancers in general, without regard for strain, rates have steadily increased since the vaccine’s introduction. As reported by the Kaiser Family Foundation (KFF) in July 2021,[11] “HPV-related cancers have increased significantly in the past 15 years[12] — in 2015, 43,000 people developed an HPV-related cancer compared to 30,000 in 1999.”

Oral and anal cancers related to HPV infection have also increased. Whereas cervical cancer used to be the most prevalent HPV-associated cancer, oral cancers are now the most common.[13]

HPV Vaccine Increases Risk of Cancer From Other HPVs

The primary cause for this continued rise appears to be because cancers associated with non-vaccine strains are going up. Indeed, new evidence suggests HPV vaccination makes women more susceptible than their nonvaccinated peers to HPV genotypes not covered by the vaccine.[14]

So, essentially, women who got the vaccine have just traded one risk for another. As reported by Medscape:[15]

“The data come from the Costa Rica HPV Vaccine Trial,[16] which involved more than 10,000 women aged 18-25 years. The HPV vaccine used in the trial was Cervarix, from GlaxoSmith Kline. It covers the two leading causes of cervical cancer, HPV 16 and 18, and provides partial protection against three other genotypes.

After a follow-up of 11 years, among vaccinated women, there was an excess of precancerous cervical lesions caused by genotypes not included in the vaccine, resulting in negative vaccine efficacy for those HPV variants …

The results are likely the first evidence to date of ‘clinical unmasking’ with HPV vaccination, meaning that protection against the strains covered by the vaccine leaves women more prone to attack from other carcinogenic HPV variants.

This phenomenon ‘could attenuate long-term reductions in high-grade disease following successful implementation of HPV vaccination programs,’ the investigators comment.

The take-home message from the trial is that ‘we have to be careful,’ said Marc Steben, MD, co-president of HPV Global Action and a professor in the University of Montreal’s School of Public Health.”

The Replacement Phenomenon

This “replacement phenomenon” is precisely what happened with the pneumococcal vaccine, which is why vaccine companies were forced to keep adding new strains to the vaccine. The same thing is now happening with the HPV vaccine.

HPV16 and HPV18 have historically been responsible for about 70 percent of cervical cancer cases,[17] which is why these two strains, plus HPV6 and HPV11, were included in the original quadrivalent Gardasil vaccine released in 2006.

In December 2014, Gardasil was updated to include five additional strains — HPV31, 33, 45, 52 and 58 — for a total of nine.[18]

Overall, these nine HPVs are responsible for the vast majority of HPV-related cancers, including cervical, throat and anal cancers, as well as most genital warts. (Cervarix, another HPV vaccine, is available in Europe and other parts of the world, but since 2017, Gardasil®9 is the only HPV vaccine approved for use in the U.S.)

Serious Adverse Reactions Are Still Downplayed

While the medical establishment maintains that Gardasil is safe and has few side effects, a significant number of young girls and boys have been seriously injured over the years. Serious adverse reactions reported to the Vaccine Adverse Event Reporting System (VAERS) in relation to Gardasil include but are not limited to the following:[19]

• Anaphylaxis
• Guillain-Barre Syndrome
• Transverse myelitis (inflammation of the spinal cord)
• Pancreatitis
• Venous thromboembolic events (blood clots)
• Autoimmune initiated motor neuron disease (a neurodegenerative disease that causes rapidly progressive muscle weakness)
• Multiple sclerosis (MS)
• Sudden death

All of these side effects are acknowledged by the FDA[20] and are included in Gardasil’s labeling. In addition to these, the Gardasil vaccine insert also lists:[21]

• Blood and lymphatic system disorders such as autoimmune hemolytic anemia, idiopathic thrombocytopenic purpura and lymphadenopathy
• Pulmonary embolus
• Arthralgia and myalgia (musculoskeletal and connective tissue disorders)
• Nervous system disorders such as acute disseminated encephalomyelitis

Safety Signal Detected for Premature Ovarian Insufficiency

According to a study[22] published in July 2020, VAERS data mining also revealed a disproportionate number of reports of premature ovarian insufficiency (POI) and related problems, including amenorrhea (absence of menstruation), irregular menses, increased follicle-stimulating hormone (FSH) and premature menopause.

POI[23] is when a woman’s ovaries stop working normally before the age of 40, which reduces her chances of getting pregnant. It also raises her risk for anxiety and depression, certain eye diseases, heart disease, hypothyroidism (low thyroid function) and osteoporosis (low bone density).

According to the authors:[24]

“The signal was detected by the methods of Bayesian Confidence Propagation Neural Network (BCPNN) and Multi-item Gamma Poisson Shrinker (MGPS). When both methods detected a positive result, a signal was generated.

Besides, time-scan map is drawn based on the IC value and 95 percent CI of BCPNN, if the IC curve showed a steady upward trend and the 95 percent CI narrowed, the signal was stable and strong association … Our results only represent statistical association between HPV vaccine and POI related events, causal relationship needs further investigation.”

Concern Over Gardasil Safety Is Rising

Over the years, parents have gotten increasingly concerned about the safety of Gardasil. According to a 2021 investigation,[25] 23 percent of parents who declined HPV vaccination for their child in 2018 cited concerns about safety, compared to 13 percent in 2015.

Normally, drugs become more accepted over time as their safety is demonstrated in the real world. Not so with Gardasil, however, which could be an indication that more and more people know or have heard of youngsters suffering serious problems.[26]

The fact of the matter is that tolerance for Gardasil-induced harm ought to be far lower than it is.

It should be extremely low for the simple fact that the vaccine is given to perfectly healthy children and teens whose future risk of dying from cervical cancer is zero at the time it’s given, and only 2.2 per 100,000[27] by the time they’re 58. Also, it’s worth noting that risk factors for HPV infection among young females are:[28]

• Early age of sexual debut
• Multiple lifetime sexual partners
• Short intervals between different partners
• Use of hormonal contraceptives
• Smoking
• Diet deficient in certain micronutrients

So, considering that the main risk factors are modifiable behavior choices, wouldn’t it make more sense to encourage young females to work on avoiding the risks, as opposed to simply counting on the vaccine to protect them?

Additionally, a woman’s lifetime risk of a cervical cancer diagnosis is only 0.7 percent, so it’s hardly a concern worth taking significant risks to avoid.

The threshold of tolerance for vaccine-induced risks is further lowered by the fact that it’s a mandated requirement for school attendance in some jurisdictions, and is available without parental consent in others.

There’s also ample evidence showing that inexpensive Pap smears are the most effective way to identify an HPV infection and, by treating it, preventing it from turning into cancer.

Merck Accused of Fraud in Gardasil Safety Testing

There are other reasons to be suspicious of Gardasil’s safety as well. According to Robert F. Kennedy Jr., Merck committed fraud in its safety testing by:

• Testing Gardasil against a toxic placebo, and
• Hiding a 2.3 percent incidence of autoimmune disease occurring within seven months of vaccination

Table 1 in the package insert[29] for Gardasil looks at vaccine injuries at the site of injection. It shows that Gardasil was administered to 5,088 girls; another 3,470 received the control, amorphous aluminum hydroxyphosphate sulfate (AAHS) — a neurotoxic aluminum vaccine adjuvant that has been associated with many serious vaccine injuries in the medical literature.

AAHS is also the adjuvant used in Gardasil, so it’s hardly a reasonable control. They basically tested the complete vaccine against its most toxic component.

A third group, consisting of 320 individuals, received a proper placebo (saline). In the Gardasil and AAHS control groups, the number of injuries were fairly close; 83.9 percent in the Gardasil group and 75.4 percent in the AAHS control group. Meanwhile, the rate of injury (again, relating to injuries at the injection site only), was significantly lower at 48.6 percent.

Table 9 from the vaccine insert is the “Summary of girls and women 9 through 26 years of age who reported an incident condition potentially indicative of a systemic autoimmune disorder after enrollment in clinical trials of Gardasil, regardless of causality.” These conditions include serious systemic reactions, chronic and debilitating disorders and autoimmune diseases.

Now all of a sudden, there are only two columns, not three as shown for the injection site injuries. The column left out is that of the saline placebo group. According to Kennedy, Merck cleverly hid the hazards of Gardasil by combining the saline group with the aluminum control, thereby watering down the side effects reported in the controls.

Looking at the effects reported in the two groups, 2.3 percent of those who received Gardasil reported an effect of this nature, as did 2.3 percent of those receiving the AAHS (aluminum) control or saline placebo. The same exact ratio of harm is reported in both groups, which makes it appear as though Gardasil is harmless.

In reality, the vast majority of the controls were given a toxic substance, and they don’t tell us how many of those receiving a truly inert substance developed these systemic injuries.

Still, we can draw some educated guesses, seeing how the injection site injury ratios between Gardasil and the aluminum group were similar.

In short, Merck’s use of AAHS, a neurotoxic aluminum adjuvant instead of a biologically inactive placebo, effectively nullifies its prelicensure Gardasil safety testing.

This is taken from a long document. Read the rest here theepochtimes.com

Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.